A
Arthritis Clinical Trial Centre | Cape Town, South Africa
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Baricitinib
Zetomipzomib
LY3009104
Filgotinib
KZR-616
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...
Active, not recruiting
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor
Locations recently updated
The purpose of this study is to assess the efficacy and safety of zetomipzomib (30 mg or 60 mg) compared with placebo in achieving renal response aft...
Enrolling
Lupus Nephritis
Drug: placebo
Drug: zetomipzomib
The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the...
Active, not recruiting
Rheumatoid Arthritis
Drug: Filgotinib
Drug: Placebo to match filgotinib
Trial sponsors
G
K
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems